Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design.

Saved in:
Bibliographic Details
Title: Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design.
Authors: Nickerson, Peter W.1 (AUTHOR), Böhmig, Georg A.2 (AUTHOR), Chadban, Steve3 (AUTHOR), Kumar, Deepali4 (AUTHOR), Mannon, Roslyn B.5 (AUTHOR), van Gelder, Teun6 (AUTHOR), Lee, James C.7 (AUTHOR) james.lee2@cslbehring.com, Adler, Scott7 (AUTHOR), Chong, Edward7 (AUTHOR), Djamali, Arjang8 (AUTHOR)
Source: Trials. 12/22/2022, Vol. 23 Issue 1, p1-12. 12p. 1 Diagram, 4 Charts.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 160936859
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Nickerson%2C+Peter+W%2E%22">Nickerson, Peter W.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Böhmig%2C+Georg+A%2E%22">Böhmig, Georg A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chadban%2C+Steve%22">Chadban, Steve</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kumar%2C+Deepali%22">Kumar, Deepali</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mannon%2C+Roslyn+B%2E%22">Mannon, Roslyn B.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Gelder%2C+Teun%22">van Gelder, Teun</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee%2C+James+C%2E%22">Lee, James C.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<i> james.lee2@cslbehring.com</i><br /><searchLink fieldCode="AR" term="%22Adler%2C+Scott%22">Adler, Scott</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chong%2C+Edward%22">Chong, Edward</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Djamali%2C+Arjang%22">Djamali, Arjang</searchLink><relatesTo>8</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Trials%22">Trials</searchLink>. 12/22/2022, Vol. 23 Issue 1, p1-12. 12p. 1 Diagram, 4 Charts.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=160936859
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13063-022-06897-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 1
    Titles:
      – TitleFull: Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nickerson, Peter W.
      – PersonEntity:
          Name:
            NameFull: Böhmig, Georg A.
      – PersonEntity:
          Name:
            NameFull: Chadban, Steve
      – PersonEntity:
          Name:
            NameFull: Kumar, Deepali
      – PersonEntity:
          Name:
            NameFull: Mannon, Roslyn B.
      – PersonEntity:
          Name:
            NameFull: van Gelder, Teun
      – PersonEntity:
          Name:
            NameFull: Lee, James C.
      – PersonEntity:
          Name:
            NameFull: Adler, Scott
      – PersonEntity:
          Name:
            NameFull: Chong, Edward
      – PersonEntity:
          Name:
            NameFull: Djamali, Arjang
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 12
              Text: 12/22/2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 17456215
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Trials
              Type: main
ResultId 1